RPRX
STRONGRoyalty Pharma plc
CIK: 0001802768
Last activity: 3 days ago
Financial Metrics
As of Dec 31, 2025 (10-K)
Insider Roster (3 total, 3 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
|
Coyne Terrance P.
EVP & CFO
|
0 | 22 | -$24.91M |
32,916 shares
$1.59M
|
|
Urist Marshall
EVP, Research & Investments
|
0 | 10 | -$7.95M |
Holdings: -
Value: -
|
|
Lloyd George W.
EVP, Investments & CLO
|
0 | 2 | -$4.24M |
Holdings: -
Value: -
|
Recent Transactions
32,916 shares @ $48.33
$1.59M
Apr 1, 2026
1,875 shares @ $48.33
$91K
Apr 1, 2026
32,916 shares @ $45.53
$1.50M
Mar 23, 2026
1,875 shares @ $45.53
$85K
Mar 23, 2026
22,487 shares @ $46.67
$1.05M
Mar 2, 2026
10,429 shares @ $47.01
$490K
Mar 2, 2026
1,292 shares @ $46.67
$60K
Mar 2, 2026
583 shares @ $47.01
$27K
Mar 2, 2026
32,916 shares @ $45.32
$1.49M
Feb 23, 2026
1,875 shares @ $45.32
$85K
Feb 23, 2026
19,076 shares @ $43.29
$826K
Feb 4, 2026
1,087 shares @ $43.29
$47K
Feb 4, 2026
108,759 shares @ $42.84
$4.66M
Feb 3, 2026
6,195 shares @ $42.84
$265K
Feb 3, 2026
102,581 shares @ $42.08
$4.32M
Feb 2, 2026
5,843 shares @ $42.08
$246K
Feb 2, 2026
20,000 shares @ $41.09
$822K
Jan 30, 2026
20,000 shares @ $40.26
$805K
Jan 23, 2026
65,832 shares @ $39.35
$2.59M
Jan 20, 2026
3,750 shares @ $39.35
$148K
Jan 20, 2026
20,000 shares @ $39.52
$790K
Jan 16, 2026
20,000 shares @ $40.78
$816K
Jan 9, 2026
65,832 shares @ $38.42
$2.53M
Jan 2, 2026
20,000 shares @ $38.48
$770K
Jan 2, 2026
3,750 shares @ $38.42
$144K
Jan 2, 2026
20,000 shares @ $39.32
$786K
Dec 26, 2025
20,000 shares @ $38.38
$768K
Dec 19, 2025
30,654 shares @ $38.50
$1.18M
Dec 18, 2025
79,346 shares @ $38.57
$3.06M
Dec 17, 2025
20,000 shares @ $38.32
$766K
Dec 16, 2025
65,832 shares @ $38.36
$2.53M
Dec 15, 2025
3,750 shares @ $38.36
$144K
Dec 15, 2025
23,334 shares @ $39.15
$914K
Dec 5, 2025
18,242 shares @ $39.15
$714K
Dec 5, 2025
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.